Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) 347.3496.47-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 347.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025347.34
Mar202496.47
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2025 347.34
260.05
Mar2024 96.47
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹87.5 Cr 5.3% -10.2% -48.7% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹8,134.6 Cr -3.1% -17.4% 5.8% Stock Analytics
KIRI INDUSTRIES ₹3,166.8 Cr -0.6% -5.5% 22.7% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,862.0 Cr 10.6% 4.6% -28% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,341.5 Cr 9.9% 4.1% 48.4% Stock Analytics
BODAL CHEMICALS ₹726.3 Cr -3.6% -3.9% -24.1% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

5.3%

-10.2%

-48.7%

SENSEX

1.6%

2.7%

6.3%


You may also like the below Video Courses